Jobs / United States / Regeneron Pharmaceuticals INC
Director Integrated Data Quality
Regeneron Pharmaceuticals INC · 🇺🇸 3 Locations
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 290 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 40 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Regeneron Pharmaceuticals INC paid sponsored hires in similar roles1 certified filing for “Associate Director – Clinical Data Operations” (Database Architects) in NJ: $197k–$197k, median $197k. Most were filed at wage level IV (100%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Regeneron Pharmaceuticals INC
The US Department of Labor certified 290 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 40 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Regeneron Pharmaceuticals INC →
About the role
Build our future together: The Director, Integrated Data Review provides strategic leadership for the development, implementation, and continuous improvement of integrated data review processes across clinical programs. In partnership with Biostatistics and cross-functional collaborators, this role establishes scalable frameworks, standards, and oversight models to enable proactive, risk-based identification of data issues and ensure high-quality, inspection-ready clinical data. The position drives consistent execution of Data Review Plans and promotes adoption of integrated data review practices across study teams. When & where: • Location: Warren NJ, Armonk NY, and TarryTown NY • Work model/flexibility: on site 4 days a week • Travel percentage: 10% Discover your role: • Define and lead the Integrated Data Review (IDR) strategy, including the implementation of an appropriate operating model, and governance framework across the portfolio. • Accountable for consistent execution, oversight, and critical issue of Data Review Plans (DRPs), and proactive identification of data quality risks. • Define minimum requirements and develop standardized data review plans methodologies, templates, processes, and guidance to enable consistent and effective execution across study teams. • Provide oversight of data review plans execution through established governance processes, KPIs, and quality metrics to ensure consistency, effectiveness, adherence to standards, and continuous improvement across programs. • Partner with the Clinical Data Reporting group to develop, implement, and maintain standardized libraries of data review outputs, including visualizations, listings, dashboards, and patient profiles, that support scalable and consistent execution of integrated data review processes across programs. • Collaborate with Quantitative Innovation and Statistical Strategy (QISS) team to translate Risk-Based Data Management (RBDM) methodologies into practical data review approaches and study-level requirements. • Proactively identify potential risks to data quality, integrity, and delivery timelines and implement mitigation strategies to ensure continuity, compliance, and successful delivery of departmental objectives. • Drive continuous improvement and innovation in IDR methodologies and technologies through analysis of metrics, lessons learned, inspection observations, and evolving industry practices. • Develop and maintain SOPs, work instructions, templates, and training materials using quality-by-design principles to support integrated data review processes. • Lead implementation, change management, and training initiatives to ensure consistent adoption. • Drive adoption of IDR methodologies across clinical and external data domains to support proactive issue detection and improved data quality outcomes. • Liaise with internal and external collaborators to develop strong relationships and ensure effective cross-functional collaboration and communication with respect to deliverables and throughout drug development process. This role requires: • 12+ years in Clinical Data Management within within the biotechnology, pharmaceutical or health related industry. With 5+ years of people management, leadership, and mentoring • Expert knowledge of clinical data management principles, processes, technologies and industry best practices. • Expert knowledge of integrated data review principles, data quality management, and critical-to-quality concepts. • Deep understanding of regulatory requirements and industry standards, including ICH E6 (R3), ICH E8 (R1), GxP, 21 CFR Part 11, and global data privacy regulations, with the ability to apply these in an operational setting. • Working knowledge of RBDM principles and their application t